secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aldeyra Therapeutics, Inc. (ALDX)
CIK:        0001341235
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001193125-24-191518
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aldeyra Therapeutics enters into $75M at-the-market equity offering with Jefferies
--------------------------------------------------------------------------------

- New Open Market Sale Agreement with Jefferies LLC to sell up to $75M of common stock.
- Prior $100M sales agreement terminated; no sales made under prior agreement.
- Agent compensation: up to 3% of gross sales price; Company may designate minimum price.
- Company has no obligation to sell any shares; agreement can be terminated by either party.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341235/000119312524191518/0001193125-24-191518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341235/000119312524191518/d814773d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-191518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer